Literature DB >> 20122312

Coagulation profiling of random-source cats.

Elizabeth McGeehan1, Karen Wielgus, Lee Cera, Farshid Azarafrooz, Rose Buesing, Jean Dubach, Jawed Fareed.   

Abstract

The chemistry and hemostatic parameters of class B vendor cats (Felis catus) can show wide levels of variation, possibly because of initial health status. We compared prothrombin time, partial thromboplastin time, common pathway assay and thrombin time between Class B vendor cats (n = 30) and a control group of healthy cats (n = 16). The antiprotease activities of antiXa, antiIIa, heparin cofactor II, and antithrombin were measured also. Plasma samples from citrated blood were analyzed by using standard clotting assays and commercially available chromogenic substrate assays. Tests for homogeneity of variances and 1-way ANOVA were used to test for significant differences between groups. Results of ANOVA were highly significant between groups for heparin cofactor II and Heptest activity levels. Variances were significantly different between groups for prothrombin time; therefore, an ANOVA was not done. These studies suggest that the class B cats exhibited sufficiently wide variations in their coagulation parameters that they may not be optimal subjects for vascular or cardiovascular research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122312      PMCID: PMC2824963     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  16 in total

1.  Evaluation of plasma antithrombin activity and D-dimer concentration in populations of healthy cats, clinically ill cats, and cats with cardiomyopathy.

Authors:  Jennifer L Brazzell; Dori L Borjesson
Journal:  Vet Clin Pathol       Date:  2007-03       Impact factor: 1.180

2.  Plasma heparin: a unique, practical, submicrogram-sensitive assay.

Authors:  E T Yin; S Wessler; J V Butler
Journal:  J Lab Clin Med       Date:  1973-02

Review 3.  Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractions.

Authors:  D A Hoppensteadt; J M Walenga; J Fareed
Journal:  Semin Thromb Hemost       Date:  1985-04       Impact factor: 4.180

Review 4.  Heparin cofactor II modulates the response to vascular injury.

Authors:  Douglas M Tollefsen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-28       Impact factor: 8.311

Review 5.  Families and clans of serine peptidases.

Authors:  A J Barrett; N D Rawlings
Journal:  Arch Biochem Biophys       Date:  1995-04-20       Impact factor: 4.013

6.  Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.

Authors:  M J Griffith; C M Noyes; F C Church
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

7.  Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions.

Authors:  J M Walenga; L Bara; M M Samama; J Fareed
Journal:  Semin Thromb Hemost       Date:  1985-04       Impact factor: 4.180

8.  Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity.

Authors:  E Persson; H Bak; O H Olsen
Journal:  J Biol Chem       Date:  2001-06-01       Impact factor: 5.157

9.  Hypercoagulability in cats with cardiomyopathy.

Authors:  T Stokol; M Brooks; J E Rush; M Rishniw; H Erb; E Rozanski; M S Kraus; A R Gelzer; A L Gelzer
Journal:  J Vet Intern Med       Date:  2008-05-02       Impact factor: 3.333

10.  Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy.

Authors:  Christian Bédard; Anne Lanevschi-Pietersma; Marilyn Dunn
Journal:  Vet Clin Pathol       Date:  2007-06       Impact factor: 1.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.